EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES
Clinical trials for EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES explained in plain language.
Never miss a new study
Get alerted when new EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES trials appear
Sign up with your email to follow new studies for EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Tailored immune cells take on childhood brain cancer in first human test
Disease control Recruiting nowThis early-phase study tests whether a personalized immune cell treatment is safe for children under 5 with certain brain tumors. The treatment uses the child's own immune cells, trained to attack unique markers from their tumor. Up to 12 children will receive the therapy after s…
Matched conditions: EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES
Phase: PHASE1 • Sponsor: Children's National Research Institute • Aim: Disease control
Last updated May 26, 2026 11:16 UTC
-
New drug cocktail aims to stall childhood cancers
Disease control Recruiting nowThis study tests a new oral drug, AMXT 1501, combined with another drug called DFMO for children and young adults (up to age 21) with certain cancers like neuroblastoma, brain tumors, and sarcomas. The first part finds the safest dose, and the second part checks if the combo help…
Matched conditions: EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES
Phase: PHASE1, PHASE2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New hope for kids with rare brain cancer: aggressive combo therapy under study
Disease control Recruiting nowThis study is for children newly diagnosed with a very rare and aggressive brain tumor called ETMR. Researchers are testing whether a strong mix of chemotherapy drugs followed by high-dose chemo and focused radiation can help keep the tumor from growing back. About 70 children wi…
Matched conditions: EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
New hope for toddlers with rare brain cancers: targeted chemo combo under study
Disease control Recruiting nowThis early-phase study tests whether adding a chemotherapy drug (topotecan) given into the spinal fluid, followed by maintenance chemo, is safe and feasible for children under 6 with high-risk embryonal brain tumors. The goal is to improve cancer control after standard high-dose …
Matched conditions: EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES
Phase: EARLY_PHASE1 • Sponsor: C17 Council • Aim: Disease control
Last updated May 18, 2026 12:03 UTC